NCT02479399View on ClinicalTrials.gov

Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

CompletedOBSERVATIONAL
Enrollment

11,412

Participants

Timeline

Start Date

July 17, 2014

Primary Completion Date

October 16, 2018

Study Completion Date

October 16, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

ipragliflozin

Tablets

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY